D.E. Shaw & Co
BIOA

D.E. Shaw & Co’s BioAge Labs BIOA Stock Holding History

D.E. Shaw & Co’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Buy
699,190
+359,281
+106% +$6.92M 0.01% 1476
2025
Q4 		$4.5M Buy
339,909
+235,628
+226% +$2.09M ﹤0.01% 2397
2025
Q3 		$613K Buy
104,281
+36,883
+55% +$173K ﹤0.01% 3754
2025
Q2 		$278K Buy
+67,398
New +$272K ﹤0.01% 3916

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co's BIOA Position: Q1 2026 in Review

D.E. Shaw & Co increased its BioAge Labs (BIOA) stake by 106% in Q1 2026, buying an estimated $6.92M and bringing the position to 699,190 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #1476.

D.E. Shaw & Co first reported a position in BIOA in Q2 2025 and has held it in 4 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • D.E. Shaw & Co held 699,190 shares of BioAge Labs worth $12.2M as of Q1 2026.
  • D.E. Shaw & Co bought 359,281 BioAge Labs shares in Q1 2026, an estimated $6.92M.
  • BioAge Labs made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1476 holding.
  • D.E. Shaw & Co first reported a position in BioAge Labs in Q2 2025 and has held it in 4 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.